NTRA Q2 2024 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$29B

Q2 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$413M+58.1% YoY

Gross Profit

$243M58.8% margin

Operating Income

-$44M-10.6% margin

Net Income

-$37M-9.1% margin

EPS (Diluted)

$-0.30

QoQ Revenue Growth

+12.4%

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

-$8M

Stock-Based Comp.

$67M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$680M

Stockholders' Equity

$837M

Cash & Equivalents

$797M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$413M	$261M	+58.1%
Gross Profit	$243M	$118M	+105.6%
Operating Income	-$44M	-$112M	+61.0%
Net Income	-$37M	-$111M	+66.2%

Revenue Segments

Product

$411M100%

Licensing and other

$2M0%

Geographic Segments

United States

$405M98%

Europe, Middle East, India, Africa

$5M1%

Americas, excluding U.S.

$2M0%

Asia Pacific and Other

$1M0%